Chin‐Chou Wang

机构：Chang Gung University of Science and Technology, Kaohsiung Medical University, National Health Research Institutes, Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, Taipei Medical University, Academia Sinica · ORCID：0000-0003-2932-751X

发表论文 167 篇 · 总被引 6358 次 · h-index 33

代表论文

• Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma (2024 · JAMA Oncology · 被引 58)
• Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan (2023 · Targeted Oncology · 被引 27)
• KEYNOTE ‐033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD‐L1‐positive , advanced NSCLC (2023 · International Journal of Cancer · 被引 26)
• Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC (2023 · Scientific Reports · 被引 22)
• Levels of organophosphate flame retardants and their metabolites among 391 volunteers in Taiwan: difference between adults and children (2023 · Frontiers in Public Health · 被引 18)
• Association between organophosphate flame retardant exposure and lipid metabolism: data from the 2013–2014 National Health and Nutrition Examination Survey (2024 · Frontiers in Public Health · 被引 17)